View in browser

Please find the next edition of the Monthly Infectious Diseases Summary, our subjective look at the most important news of the month. Please let us know how you like it and if there is something interesting, we missed by contacting us at nac.contact@lgcgroup.com

Sudan Virus Outbreak in Uganda: What You Need to Know

As of February 20, 2025, Uganda has reported nine confirmed cases of Sudan virus disease (SVD), including one death, since the outbreak was declared on January 30. SVD, a severe illness related to Ebola, has a high fatality rate, and no approved vaccines or treatments exist. Health authorities are closely monitoring the situation, enforcing strict surveillance, and implementing control measures. Read More >>

Discover our full offer of Ebola antigens and antibodies, and contact us if you require custom protein manufacture at nac.contact@lgcgroup.com

Marburg Virus Disease Outbreak in Tanzania: Latest Update

As of February 25, 2025, Tanzania’s Marburg Virus Disease (MVD) outbreak in Kagera has resulted in 10 cases (two confirmed, eight probable), all fatal. The last confirmed death was reported on February 10. The Ministry of Health, with WHO support, deployed a rapid response team, enhanced surveillance, and continues laboratory testing. MVD, similar to Ebola, spreads via bodily fluids and contaminated surfaces. Symptoms include fever, headache, and potential haemorrhagic manifestations. No approved treatments or vaccines exist. Read More >>

At TNAC we offer a Marburg virus GP proteins and a range of antibodies, do not hesitate to reach out if you have any questions about our antigens and antibodies.

Measles Outbreak Spreads Across the U.S., 2nd Death in a Decade Reported

The measles outbreak, which began in Texas and quickly spread to other U.S. states, has resulted in over 160 confirmed cases, with 95% of those affected being unvaccinated, according to the CDC. The first fatality, a school-age child in Texas, marks the first measles death in the U.S. in a decade. A second death has been reported in New Mexico, where an unvaccinated adult, who did not seek medical care before passing away, later tested positive for the virus. Read More >>

See our full range of Measles products here as well as our Rubella portfolio.

Autochthonous Chikungunya Virus Disease – La Réunion, France (2024–2025)

As of February 16, 2025, La Réunion has reported 1,069 autochthonous chikungunya cases, with 927 in 2025. The outbreak continues to spread, with 362 new cases in week 6 across 21 municipalities. Le Tampon (228 cases) and L'Étang-Salé (169 cases) report the highest numbers. The epidemic is considered low-intensity, with limited hospitalizations. Local authorities activated Level 3 of the ORSEC 'Arboviruses' system and reinforced vector control, public awareness, and insecticide measures. The ECDC is monitoring the situation, and travelers are advised to take mosquito bite precautions as Aedes albopictus remains active in La Réunion’s austral summer. Read More >>

At TNAC we offer a wide range of Chikungunya Virus reagents, including Chikungunya VLPs. Read our newest white paper about these VLPs here.

The Latest from The Native Antigen Company

Just Launched:

C.diff Antigens

We’re thrilled to announce the release of 4 new Clostridium difficile toxin Antigens, including Ribotyping 087 and 027 Toxin A and B, now available to enhance your diagnostics.